Tergus Hires Michele Nathan Borek
The following release just went over the newswire. We are very pleased the Michele Nathan Borek has joined Tergus!
Tergus Hires Leading Sales and Marketing Executive
Michele Nathan Borek has more than 20 years of experience in creating growth for life science companies
Research Triangle Park, North Carolina – December 10, 2015 – Tergus (www.terguspharma.com), the industry leader in topical pharmaceutical development, skin biology & IVRT testing and Phase I – III cGMP clinical supply manufacturing, has hired Michele Nathan Borek to head the company’s sales and marketing efforts. Tergus continues to attract top talent with the hire of Ms. Borek, who has more than 20 years of experience in implementing successful marketing and sales efforts for life science companies.
“We are very pleased to have Michele join Tergus as Director of Sales and Marketing,” said Vijendra Nalamothu, PhD, CEO and co-founder of Tergus. “She has a stellar record and deep experience in leading growth efforts for life science companies.”
Ms. Borek holds an MBA in marketing from Oklahoma City University and a BS in biology from Ursinus College. She has held a number of sales and marketing leadership positions for life science companies. Her professional career has been spent implementing programs that have resulted in growth and success for the companies she has been affiliated with.
The hiring of Ms. Borek is another step in Tergus’ strong commitment to excellence. The company has enjoyed strong growth for the past few years and has attracted top talent in topical formulation, development, testing, analysis and manufacturing. It continues to grow its footprint, recently expanding to a more than 28,000 square-foot facility that includes top-of-the-line R&D labs, GMP manufacturing suite and the largest capability in the industry for IVRT and skin permeation studies. Tergus pioneered QbD for topical pharmaceuticals and continues to innovate and develop strategies that result in greater success for its clients.
Tergus offers complete topical pharmaceutical consulting services, development, formulation, analytical R&D, In Vitro Release Testing (IVRT), skin biology and cGMP clinical supplies manufacturing. The company has capability to produce clinical supplies up to 150kg using their state of the art manufacturing equipment. The company’s motto is “Think Topical, Think Tergus.”
Tergus (www.terguspharma.com) is the market leader in full-service topical pharmaceutical research, development, testing and manufacturing. The company is the leader in topical pharmaceuticals with more than 20 years in business and has a state-of-the-art laboratory facility in Durham, North Carolina. The company has a long and stellar reputation for delivering quality and results for clients from formulation through manufacturing. The company’s motto is “Think Topical. Think Tergus.”
- Tergus Pharma Announces New Commercial Manufacturing Facility and Partnership with Great Point Partners
- Large vs. Small – Why small, agile manufacturing operations trump large companies
- SUPAC-SS GUIDANCE EXPLAINED – When In Vitro Release Testing (IVRT) is Required for Semisolid Products
- Continuous Manufacturing and Semi-Solids
- Skin Cancer Drug Fast-tracked to Patients in UK